Jasmijn de Rooij

Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes

Jasmijn de Rooij, Cristyn Branstetter, Jing Ma et al. · Nature Genetics · 2017 · 219 citations · Full text

Down Syndrome, Hematological Malignancy, Pediatric Hematology +10

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

Jasmijn de Rooij, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters et al. · Leukemia · 2013 · 150 citations

Hematological Malignancy, Genetics, Molecular Genetics +5

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

Jasmijn de Rooij, Riccardo Masetti, Marry M. van den Heuvel‐Eibrink et al. · Blood · 2016 · 114 citations · Full text

Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia

Marissa A. H. den Hoed, Elixabet López-López, M.L. te Winkel et al. · The Pharmacogenomics Journal · 2014 · 71 citations · Full text

Hematological Malignancy, Methotrexate-induced Mucositis, Pediatric Hematology +9

Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia

Jasmijn de Rooij, Eva Beuling, Marry M. van den Heuvel‐Eibrink et al. · Haematologica · 2015 · 70 citations · Full text